发明名称 |
MODULATED LYSINE VARIANT SPECIES COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME |
摘要 |
The instant invention relates to modulated lysine variant species compositions comprising a protein, e.g., an antibody, or antigen-binding portion thereof, and methods, e.g., cell culture and/or protein purification methods, for producing such modulated lysine variant species compositions. Methods for using such compositions to treat a disorder, e.g., a disorder in which TNFα is detrimental, are also provided. |
申请公布号 |
US2016237150(A1) |
申请公布日期 |
2016.08.18 |
申请号 |
US201514923966 |
申请日期 |
2015.10.27 |
申请人 |
AbbVie Inc. |
发明人 |
Subramanian Kartik;Thiele Mayda Perez;Zeng Xiaobei;Wong Chee Furng;Kaymakcalan Zehra;Jing Ying;Chumsae Christopher M. |
分类号 |
C07K16/24;C12P21/00 |
主分类号 |
C07K16/24 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for producing a composition comprising a human anti-TNFα antibody, comprising
culturing a cell producing the antibody in a cell culture media comprising an amount of one or more basic amino acids sufficient to produce a composition comprising the antibody in which less than 65% of the lysine variant species of the antibody have zero C-terminal lysines (Lys 0), wherein the lysine variant species include the main peak and peaks that elute at a relative residence time later than the main peak, as detected using weak cation-exchange chromatography, and wherein the antibody comprises a light chain variable region (LCVR) having a CDR1 domain comprising the amino acid sequence of SEQ ID NO:7, a CDR2 domain comprising the amino acid sequence of SEQ ID NO:5, and a CDR3 domain comprising the amino acid sequence of SEQ ID NO:3; and a heavy chain variable region (HCVR) having a CDR1 domain comprising the amino acid sequence of SEQ ID NO:8, a CDR2 domain comprising the amino acid sequence of SEQ ID NO:6, and a CDR3 domain comprising the amino acid sequence of SEQ ID NO:4. |
地址 |
North Chicago IL US |